Filing Details
- Accession Number:
- 0001181431-13-022280
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-04-16 16:13:33
- Reporting Period:
- 2013-04-16
- Filing Date:
- 2013-04-16
- Accepted Time:
- 2013-04-16 16:13:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113148 | Infinity Pharmaceuticals Inc. | INFI | Pharmaceutical Preparations (2834) | 330655706 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1450996 | Beacon Co | C/O Ogier House, The Esplanade St. Helier Jersey Channel Islands JE4 9WG | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-04-16 | 5,708,282 | $38.40 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Rosebay Medical Company L.P. held a 50% economic interest on behalf of Beacon Company in one share of the Common Stock sold by Rosebay Medical Company L.P. in the same transaction in which Beacon Company sold its shares.